Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Jacobson-Kram

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Toxicologic Pathology|November 6, 2009
Cancer risk assessment approaches at the FDA/CDER: Is the era of the 2-year bioassay drawing to a close?David Jacobson-Kram
International Journal of Toxicology|July 26, 2005
Use of genotoxicity data to support clinical trials or positive genetox findings on a candidate pharmaceutical or impurity .... now what?David Jacobson-Kram, Abigail Jacobs
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 14, 2004
Human carcinogenic risk evaluation, Part III: Assessing cancer hazard and risk in human drug developmentAbigail Jacobs, David Jacobson-Kram
Advanced Drug Delivery Reviews|December 26, 2006
Toxicological overview of impurities in pharmaceutical productsDavid Jacobson-Kram, Timothy McGovern
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Leveraging exploratory investigational new drug studies to accelerate drug developmentDavid Jacobson-Kram, George Mills
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 30, 2006
Genetic toxicity assessment: employing the best science for human safety evaluation. Part I: Early screening for potential human mutagensDavid Jacobson-Kram, Joseph F Contrera
Toxicologic Pathology|June 24, 2004
Use of transgenic mice in carcinogenicity hazard assessmentDavid Jacobson-Kram, Frank D Sistare, Abigail C Jacobs
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|July 9, 2003
Distribution and toxicity resulting from adenoviral vector administration to a single salivary gland in adult ratsBrian C O'Connell, Changyu Zheng, David Jacobson-Kram, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|April 4, 2015
Improving prediction of carcinogenicity to reduce, refine, and replace the use of experimental animalsTodd Bourcier, Tim McGovern, Lidiya Stavitskaya, et al.
Cancer Letters|December 7, 2007
Methylphenidate and chromosome damageDavid Jacobson-Kram, Donald Mattison, Michael Shelby, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Toxicologic Pathology|November 6, 2009
Cancer risk assessment approaches at the FDA/CDER: Is the era of the 2-year bioassay drawing to a close?David Jacobson-Kram
International Journal of Toxicology|July 26, 2005
Use of genotoxicity data to support clinical trials or positive genetox findings on a candidate pharmaceutical or impurity .... now what?David Jacobson-Kram, Abigail Jacobs
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 14, 2004
Human carcinogenic risk evaluation, Part III: Assessing cancer hazard and risk in human drug developmentAbigail Jacobs, David Jacobson-Kram
Advanced Drug Delivery Reviews|December 26, 2006
Toxicological overview of impurities in pharmaceutical productsDavid Jacobson-Kram, Timothy McGovern
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Leveraging exploratory investigational new drug studies to accelerate drug developmentDavid Jacobson-Kram, George Mills
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 30, 2006
Genetic toxicity assessment: employing the best science for human safety evaluation. Part I: Early screening for potential human mutagensDavid Jacobson-Kram, Joseph F Contrera
Toxicologic Pathology|June 24, 2004
Use of transgenic mice in carcinogenicity hazard assessmentDavid Jacobson-Kram, Frank D Sistare, Abigail C Jacobs
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|July 9, 2003
Distribution and toxicity resulting from adenoviral vector administration to a single salivary gland in adult ratsBrian C O'Connell, Changyu Zheng, David Jacobson-Kram, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|April 4, 2015
Improving prediction of carcinogenicity to reduce, refine, and replace the use of experimental animalsTodd Bourcier, Tim McGovern, Lidiya Stavitskaya, et al.
Cancer Letters|December 7, 2007
Methylphenidate and chromosome damageDavid Jacobson-Kram, Donald Mattison, Michael Shelby, et al.
Pageof 4